These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 26457512)

  • 21. Epigenetic protein families: a new frontier for drug discovery.
    Arrowsmith CH; Bountra C; Fish PV; Lee K; Schapira M
    Nat Rev Drug Discov; 2012 Apr; 11(5):384-400. PubMed ID: 22498752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2,4-pyridine-dicarboxylic acid as an in vitro and in cell inhibitor.
    Kristensen LH; Nielsen AL; Helgstrand C; Lees M; Cloos P; Kastrup JS; Helin K; Olsen L; Gajhede M
    FEBS J; 2012 Jun; 279(11):1905-14. PubMed ID: 22420752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers.
    Chi P; Allis CD; Wang GG
    Nat Rev Cancer; 2010 Jul; 10(7):457-69. PubMed ID: 20574448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases.
    Mosammaparast N; Shi Y
    Annu Rev Biochem; 2010; 79():155-79. PubMed ID: 20373914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. XDS.
    Kabsch W
    Acta Crystallogr D Biol Crystallogr; 2010 Feb; 66(Pt 2):125-32. PubMed ID: 20124692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phaser crystallographic software.
    McCoy AJ; Grosse-Kunstleve RW; Adams PD; Winn MD; Storoni LC; Read RJ
    J Appl Crystallogr; 2007 Aug; 40(Pt 4):658-674. PubMed ID: 19461840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structure of the N-terminal domain of the secretin GspD from ETEC determined with the assistance of a nanobody.
    Korotkov KV; Pardon E; Steyaert J; Hol WG
    Structure; 2009 Feb; 17(2):255-65. PubMed ID: 19217396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7.
    Langer G; Cohen SX; Lamzin VS; Perrakis A
    Nat Protoc; 2008; 3(7):1171-9. PubMed ID: 18600222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor.
    Rasmussen SG; Choi HJ; Rosenbaum DM; Kobilka TS; Thian FS; Edwards PC; Burghammer M; Ratnala VR; Sanishvili R; Fischetti RF; Schertler GF; Weis WI; Kobilka BK
    Nature; 2007 Nov; 450(7168):383-7. PubMed ID: 17952055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability.
    Niesen FH; Berglund H; Vedadi M
    Nat Protoc; 2007; 2(9):2212-21. PubMed ID: 17853878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inference of macromolecular assemblies from crystalline state.
    Krissinel E; Henrick K
    J Mol Biol; 2007 Sep; 372(3):774-97. PubMed ID: 17681537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A versatile ligation-independent cloning method suitable for high-throughput expression screening applications.
    Berrow NS; Alderton D; Sainsbury S; Nettleship J; Assenberg R; Rahman N; Stuart DI; Owens RJ
    Nucleic Acids Res; 2007; 35(6):e45. PubMed ID: 17317681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection and application of recombinant antibodies as sensors of rab protein conformation.
    Nizak C; Moutel S; Goud B; Perez F
    Methods Enzymol; 2005; 403():135-53. PubMed ID: 16473583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scaling and assessment of data quality.
    Evans P
    Acta Crystallogr D Biol Crystallogr; 2006 Jan; 62(Pt 1):72-82. PubMed ID: 16369096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coot: model-building tools for molecular graphics.
    Emsley P; Cowtan K
    Acta Crystallogr D Biol Crystallogr; 2004 Dec; 60(Pt 12 Pt 1):2126-32. PubMed ID: 15572765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features.
    Harmsen MM; Ruuls RC; Nijman IJ; Niewold TA; Frenken LG; de Geus B
    Mol Immunol; 2000 Aug; 37(10):579-90. PubMed ID: 11163394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme.
    Desmyter A; Transue TR; Ghahroudi MA; Thi MH; Poortmans F; Hamers R; Muyldermans S; Wyns L
    Nat Struct Biol; 1996 Sep; 3(9):803-11. PubMed ID: 8784355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure and binding properties of a cameloid nanobody raised against KDM5B.
    Wiuf A; Kristensen LH; Kristensen O; Dorosz J; Jensen J; Gajhede M
    Acta Crystallogr F Struct Biol Commun; 2015 Oct; 71(Pt 10):1235-41. PubMed ID: 26457512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting histone demethylase KDM5B for cancer treatment.
    Fu YD; Huang MJ; Guo JW; You YZ; Liu HM; Huang LH; Yu B
    Eur J Med Chem; 2020 Dec; 208():112760. PubMed ID: 32883639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histone demethylase lysine demethylase 5B in development and cancer.
    Han M; Xu W; Cheng P; Jin H; Wang X
    Oncotarget; 2017 Jan; 8(5):8980-8991. PubMed ID: 27974677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.